BioSpace News Archive

Business

Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head of Commercial

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced the appointment of Debra M. Hussain as Senior Vice President, Head of Commercial.

July 18, 2022
·
15 min read
Deals

BD Completes Acquisition of Parata Systems

BD (Becton, Dickinson and Company) (NYSE: BDX) today announced it has completed the acquisition of Parata Systems.

July 18, 2022
·
4 min read
FDA

AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF ZONISADE™ (zonisamide oral suspension)

Azurity Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of ZONISADE™.

July 18, 2022
·
3 min read
Business

Castle Biosciences Honored with a 2022 Arizona Top Workplace Award

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been named an Arizona Top Workplace of 2022 by AZCentral , the digital home of The Arizona Republic newspaper.

July 18, 2022
·
2 min read
BioMidwest

Techmer PM Bolsters Its Quality-Management System at Illinois Plant With an Eye on Medical Devices

Techmer PM LLC has added the coveted ISO 13485:2016 certification for medical device and quality management systems at its Batavia, Ill., site.

July 18, 2022
·
3 min read
Business

VitalHub Announces Multi Year Contract with Buckinghamshire, Oxfordshire and Berkshire Integrated Care System

VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a multi-year licensing contract of subsidiary Transforming System’s SHREWD Platform and SHREWD Resilience offerings to Buckinghamshire, Oxfordshire and Berkshire Integrated Care System (“BOB ICS”).

July 18, 2022
·
5 min read
Genetown

Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™ in the US

Sesen Bio (Nasdaq: SESN ) today announced that it has made the strategic decision to voluntarily pause further development in the US of its lead asset, Vicineum.

July 18, 2022
·
8 min read
Interventional Oncology Market, Analysis 2031 | Application in the Diagnosis and Treatment of Cancer and Cancer-related Problems

The increasing demand for minimally invasive procedures is driving the growth of the global market for interventional oncology.

July 18, 2022
·
7 min read
Policy

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

July 18, 2022
·
11 min read
Deals

Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, announced that it had acquired substantially all the assets of Assisi Animal Health LLC.

July 18, 2022
·
7 min read